Literature DB >> 8585613

Assay of [3H]dihydrorotenone binding to complex I in intact human platelets.

F Blandini1, J T Greenamyre.   

Abstract

We have developed an assay for the binding of [3H]-dihydrorotenone ([3H]DHR), an analogue of the pesticide rotenone, to the mitochondrial enzyme, complex I, in intact human platelets. The highly hydrophobic nature of dihydrorotenone, which diffuses easily through biological membranes, rendered the isolation of mitochondrial fractions unnecessary. This allowed us to reduce the amount of blood required and to shorten the processing of samples considerably. [3H]-DHR binding was saturable, specific, and highly reproducible. We also found that MPP+ (1-methyl-4-phenyl-pyridinium species), which is accumulated actively by platelets, inhibited [3H]DHR specific binding in a concentration-dependent manner. This method could provide a simple tool for the study of complex I in those disorders, such as Parkinson's disease (PD), in which a defect of this enzyme has been suggested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585613     DOI: 10.1006/abio.1995.1430

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.

Authors:  Henry F VanBrocklin; Stephen M Hanrahan; Joel D Enas; Erathodiyil Nandanan; James P O'Neil
Journal:  Nucl Med Biol       Date:  2006-11-28       Impact factor: 2.408

Review 2.  Glutamate and Parkinson's disease.

Authors:  F Blandini; R H Porter; J T Greenamyre
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.